1
Whitman Michael P, Datuck Peter A: Surgical device. Power Medical Interventions, Whitman Michael P, Datuck Peter A, BIRDE Patrick J, February 8, 2007: WO/2007/016290 (395 worldwide citation)


A surgical device is provided that includes a jaw portion with a first jaw and a second jaw moveable relative to the first jaw. The surgical device also includes a shaft portion coupled to a proximal end of the jaw portion. A driver is configured to cause relative movement of the jaw portion and the ...


2

3
Whitman Michael P, Malinouskas Donald: Shaft, e.g., for an electro-mechanical surgical device. Power Medical Interventions, Whitman Michael P, Malinouskas Donald, BIRDE Patrick J, February 1, 2007: WO/2007/014355 (21 worldwide citation)


A shaft being, e.g., flexible, that includes an elongated outer sheath, at least one drive shaft disposed within the outer sheath and a ring non-rotatably mounted on the at least one rotatable drive shaft and at least one light source mounted within the shaft, such that, upon rotation of the at leas ...


4
Niddam Hildesheim Valerie, Sterimbaum Greta: Process for preparation of rosuvastatin calcium. Teva Pharmaceutical, Teva Pharmaceuticals Usa, Niddam Hildesheim Valerie, Sterimbaum Greta, BIRDE Patrick J, March 17, 2005: WO/2005/023778 (15 worldwide citation)


The present invention provides processes for preparing rosuvastatin calcium salt substantially free of impurities on an industrial scale (I).


5
Mandlik Prashant, Wagner Sigurd, Silvernail Jeffrey A, Ma Ruiqing, Brown Julia J, Han Lin: Hybrid layers for use in coatings on electronic devices or other articles. The Trustees Of Princeton University, Universal Display Corporation, Mandlik Prashant, Wagner Sigurd, Silvernail Jeffrey A, Ma Ruiqing, Brown Julia J, Han Lin, Birde Patrick J, January 28, 2010: WO/2010/011390 (13 worldwide citation)


A method for protecting an electronic device comprising an organic device body. The method involves the use of a hybrid layer deposited by chemical vapor deposition. The hybrid layer comprises a mixture of a polymeric material and a non-polymeric material, wherein the weight ratio of polymeric to no ...


6
Esmaili Ali, Mehta Sanjay, Neogi Debashis, Valenzuela Carlos A: System and method for process monitoring. Air Products and Chemicals, Esmaili Ali, Mehta Sanjay, Neogi Debashis, Valenzuela Carlos A, BIRDE Patrick J, November 6, 2008: WO/2008/133715 (13 worldwide citation)


Systems and methods are provided that allow a user to monitor, diagnose, and configure a process. A user interface may be presented that displays data received from process monitors, sensors, and multivariate models. The user interface may be interactive, allowing a user to select which composite an ...


7
Balanov Anna, Shenkar Natalia, Niddam Hildesheim Valerie: Preparation of rosuvastatin. Teva Pharmaceutical, Teva Pharmaceuticals Usa, Balanov Anna, Shenkar Natalia, Niddam Hildesheim Valerie, BIRDE Patrick J, April 12, 2007: WO/2007/041666 (12 worldwide citation)


Provided are processes for preparing intermediates of rosuvastatin and their use in preparation of rosuvastatin and rosuvastatin salts thereof.


8
Whitman Michael P, Burbank John E: Surgical cutting and stapling device. Power Medical Interventions, BIRDE Patrick J, June 12, 2003: WO/2003/047436 (11 worldwide citation)


A surgical device includes a first jaw and a second jaw disposed in opposed correspondence with the first jaw. The second jaw is mechanically coupled to the first jaw at a proximal end opposite a distal end. A cutting element is disposed within the second jaw, and a first driver is configured to mov ...


9
Lerner E Itzhak, Flashner Barak Moshe, Smit Ruud, Lamoen Richard Van, Achthoven Erwin V, Keegstra Hans: Drug microparticles. Teva Pharmaceutical, Teva Pharmaceuticals Usa, Lerner E Itzhak, Flashner Barak Moshe, Smit Ruud, Lamoen Richard Van, Achthoven Erwin V, Keegstra Hans, BIRDE Patrick J, October 18, 2007: WO/2007/117661 (11 worldwide citation)


Pharmaceutical compositions are described containing carrier particles bearing microparticles of a drug. The drug microparticles may be deposited on the carrier particles, for example, by sublimation. Preferred embodiments of these pharmaceutical compositions are suitable for administration by inhal ...


10
Hedvati Lilach, Fishman Ayelet: The use of enzymatic resolution for the preparation of intermediates of pregabalin. Teva Pharmaceutical, Teva Pharmaceuticals Usa, Hedvati Lilach, Fishman Ayelet, BIRDE Patrick J, December 13, 2007: WO/2007/143113 (8 worldwide citation)


Provided is the use of enzymatic resolution for the preparation of intermediates of pregabalin, including (3S)-cyano-5-methylhexanoic acid and salts thereof and R-(-)-3-(carbamoylmethyl)-5-methylhexanoic acid and salts thereof.



Click the thumbnails below to visualize the patent trend.